Genetic, Clinical, and Radiographic Delineation of Hallervorden-Spatz Syndrome

New England Journal of Medicine

Volumn 348, Issue 1, 2003, Pages 33-40

  Hayflick, Susan J ^a   Westaway, Shawn K ^a   Levinson, Barbara ^b   Zhou, Bing ^b   Johnson, Monique A ^a   Ching, Katherine H L ^a   Gitschier, Jane ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PANTOTHENATE KINASE;

AMINO ACID SUBSTITUTION; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DNA SEQUENCE; DYSTONIA; GENE MUTATION; GENETIC ANALYSIS; GLOBUS PALLIDUS; HALLERVORDEN SPATZ DISEASE; HUMAN; MAJOR CLINICAL STUDY; MENTAL DISEASE; NERVE DEGENERATION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; ONSET AGE; PARKINSONISM; PREDICTION; PRIORITY JOURNAL; SPEECH DISORDER;

AGE OF ONSET; BRAIN; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FOUNDER EFFECT; HALLERVORDEN-SPATZ SYNDROME; HUMANS; MAGNETIC RESONANCE IMAGING; MUTATION, MISSENSE; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); SPEECH DISORDERS;

EID: 0037413484     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa020817     Document Type: Article

References (20)

1. Dooling EC, Schoene WC, Richardson EP Jr. Hallervorden-Spatz syndrome. Arch Neurol 1974;30:70-83.
2. Swaiman KF. Hallervorden-Spatz syndrome and brain iron metabolism. Arch Neurol 1991;48:1285-93.
3. Hallervorden J, Spatz H. Eigenartige Erkrankung im extrapyramidalen System mit besonderer Beteiligung des Globus pallidus und der Substantia nigra. Z Gesamte Neurol Psychiatr 1922;79:254-302.
4. Halliday W. The nosology of Hallervorden-Spatz disease. J Neurol Sci 1995; 134:Suppl:84-91.
5. Hickman SJ, Ward NS, Surtees RA, Stevens JM, Farmer SF. How broad is the phenotype of Hallervorden-Spatz disease? Acta Neurol Scand 2001;103:201-3.
6. Jankovic J, Kirkpatrick JB, Blomquist KA, Langlais PJ, Bird ED. Late-onset Hallervorden-Spatz disease presenting as familial parkinsonism. Neurology 1985;35:227-34.
7. Coppeto JR, Lessell S. A familial syndrome of dystonia, blepharospasm, and pigmentary retinopathy. Neurology 1990;40:1359-63.
8. Zhou B, Westaway SK, Levinson B, Johnson MA, Gitschier J, Hayflick SJ. A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat Genet 2001;28:345-9.
9. Sethi KD, Adams RJ, Loring DW, el Gammal T. Hallervorden-Spatz syndrome: Clinical and magnetic resonance imaging correlations. Ann Neurol 1988;24:692-4.
10. Hallervorden J. Über eine familiäre Erkrankung im extrapyramidalen System. Dtsch Z Nervenheilkd 1924;81:204-10.
11. Roth AM, Hepler RS, Mukoyama M, Cancilla PA, Foos RY. Pigmentary retinal dystrophy in Hallervorden-Spatz disease: Clinicopathological report of a case. Surv Ophthalmol 1971;16:24-35.
12. Swisher CN, Menkes JH, Cancilla PA, Dodge PR. Coexistence of HallervordenSpatz disease with acanthocytosis. Trans Am Neurol Assoc 1972;97:212-6.
13. Luckenbach MW, Green WR, Miller NR, Moser HW, Clark AW, Tennekoon G. Ocular clinicopathologic correlation of Hallervorden-Spatz syndrome with acanthocytosis and pigmentary retinopathy. Am J Ophthalmol 1983;95:369-82.
14. Nardocci N, Rumi V, Combi ML, Angelini L, Mirabile D, Bruzzone MG. Complex tics, stereotypies, and compulsive behavior as clinical presentation of a juvenile progressive dystonia suggestive of Hallervorden-Spatz disease. Mov Disord 1994;9:369-71.
15. Guimarães J, Santos JV. Generalized freezing in Hallervorden-Spatz syndrome: Case report. Eur J Neurol 1999;6:509-13.
16. Morphy MA, Feldman JA, Kilburn G. Hallervorden-Spatz disease in a psychiatric setting. J Clin Psychiatry 1989;50:66-8.
17. Curtis AR, Fey C, Morris CM, et al. Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet 2001;28:350-4.
18. Gitlin JD. Aceruloplasminemia. Pediatr Res 1998;44:271-6.
19. Ching KHL, Westaway SK, Levinson B, et al. HARP syndrome is allelic with pantothenate kinase-associated neurodegeneration. Neurology 2002;58:1673-4.
20. Shevell M. Racial hygiene, active euthanasia, and Julius Hallervorden. Neurology 1992;42:2214-9.